Compare CMG & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMG | IDXX |
|---|---|---|
| Founded | 1993 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3B | 43.6B |
| IPO Year | 2005 | 1996 |
| Metric | CMG | IDXX |
|---|---|---|
| Price | $32.42 | $565.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 9 |
| Target Price | $46.85 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 14.8M | 556.9K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.70 | ★ 22.59 |
| EPS | 0.23 | ★ 3.47 |
| Revenue | ★ $11,925,601,000.00 | $4,303,702,000.00 |
| Revenue This Year | $9.66 | $10.88 |
| Revenue Next Year | $11.03 | $8.59 |
| P/E Ratio | ★ $141.80 | $158.98 |
| Revenue Growth | 5.41 | ★ 10.42 |
| 52 Week Low | $29.77 | $504.56 |
| 52 Week High | $58.42 | $769.98 |
| Indicator | CMG | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 45.20 | 54.53 |
| Support Level | $31.63 | $550.28 |
| Resistance Level | $33.95 | $595.15 |
| Average True Range (ATR) | 0.95 | 16.66 |
| MACD | 0.04 | 3.15 |
| Stochastic Oscillator | 33.19 | 88.30 |
Chipotle is a leading fast-casual, Mexican-inspired restaurant chain, generating $11.9 billion in sales across 3,983 company-operated US locations, 104 international units primarily in Canada and Europe, and 14 licensed stores largely operated in the Middle East at the end of 2025. The firm's revenue is primarily driven by food and beverage sales at its company-owned restaurants, supplemented by delivery fees generated through its first-party digital channels. Chipotle emphasizes ingredients with no artificial flavors and utilizes an efficient, assembly line service model to serve mainly customizable burritos, bowls, salads, quesadillas, and tacos.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.